Ardelyx, Inc. has grown revenue 76% a year over three years and 105% a year over five. Revenue growth, 3-year annual rate: +76% (Biotechnology median +17%). Revenue growth, 5-year rate: +105%, growth has slowed since the five-year average. Years of annual history on file: 14, FY2012 to FY2025, as filed.

ARDXArdelyx, Inc.

Healthcare

$3.28-47% 1Y

$3.28

$3.2652 weeks$7.99

Is it growing?

Good

Growing: revenue growing +17% year on year and operating margin widening (+4.5 points).

2 good, 1 without data

Revenue trend+17% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +105% a year.

Margin direction+4.5 points operating

Trailing-twelve-month operating margin, -9.2% now against -13.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ARDX growing?

Ardelyx, Inc. has grown revenue 76% a year over three years and 105% a year over five.

+76%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +105%
Revenue growth, 5-year rate · +76% over three · growth has slowed since the five-year average
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›